ClinicalTrials.gg
RecruitingNCT07805486Updated Nov 4, 2026

Development of a Multimodal Deep Learning Model for Pediatric Patients

An observational study in Pediatric Obstructive Sleep Apnea and Polysomnography, sponsored by Fu Jen Catholic University. Recruiting at 1 site in Taiwan. Open to participants aged 4 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-11-04.

Sponsored by Fu Jen Catholic University · Observational

From the registry’s dates

  • Started Oct 2026; still recruiting 1 month later.
Updated Nov 4, 2026Now RecruitingSite recruiting status changed+1 moreGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
50
Ages
4 Years to 18 Years
Sex
All
01

Study summary

This study aims to develop a multimodal data-driven model integrating multiple noninvasive physiological signals to assess the severity of pediatric sleep-disordered breathing, using standard clinical sleep study results as the reference.

Read the detailed description

Pediatric obstructive sleep apnea may affect growth, development, cognitive function, and overall health. Although polysomnography is commonly used for clinical assessment, its application may be limited by time, cost, and accessibility. Recent advances in noninvasive monitoring technologies have provided new possibilities for sleep-related assessment. This study will collect and integrate multiple physiological signals from pediatric participants undergoing routine sleep examinations and to develop a data-driven model for evaluating sleep-related respiratory conditions. Clinical examination results will be used as the reference for model development and validation. The findings of this study are expected to support the development of a convenient and noninvasive approach for pediatric sleep assessment and may provide a reference for future clinical and home-based applications.

02

Conditions studied

  • Pediatric Obstructive Sleep Apnea
  • Polysomnography

Keywords

  • pediatric obstructive sleep apnea
  • polysomnography
  • smart mattress
  • millimeter-wave radar
  • multimodal deep learning
03

In context

Sleep Apnea, Obstructive

2,240 studies on the registry are indexed under Sleep Apnea, Obstructive; 475 are open to participants now.

This study's planned enrollment of 50 is below the median of 105 across 666 observational studies indexed under Sleep Apnea, Obstructive.

Browse Sleep Apnea, Obstructive studies →

Lead sponsor

Fu Jen Catholic University is the lead sponsor of 47 studies on the registry; 21 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

patient of affiliated university hospital

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Individuals with clinical suspicion of obstructive sleep apnea who are referred for polysomnography

Exclusion criteria

Exclusion Criteria:

  • Intolerance to a fingertip or wrap-around pulse oximeter
  • Presence of significant structural abnormalities of the upper airway
  • Cardiac arrhythmia
  • Neuromuscular disease
  • Hospitalization within the previous one month
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
50 participants (estimated)
Patient registry
No

Interventions

  • Devicefingertip pulse oximeter

    a small device placed on the finger to measure blood oxygen saturation and pulse rate noninvasively

  • Devicepressure-sensing mattresses

    using ballistocardiography for monitoring respiration and heart rate

  • Devicemillimeter-wave radar

    using millimeter-wave radar technology based on the Doppler effect, the device continuously monitors respiratory-related chest wall movements

06

What researchers measure

Primary outcomes

  1. the correlation among the apnea-hypopnea index, millimeter-wave radar signals, and ballistocardiography waveforms

    Time frame: up to 12 hours

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2026 (actual). Primary completion is estimated for Jul 2027, 9 months after the start.

Of 258 non-industry observational studies under Sleep Apnea, Obstructive, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 61. This study's planned 9 months is below that.

Counting every sponsor, half of 294 studies reached it within 28 months; a quarter within 14 and three quarters within 63.

Start moved once since we started tracking on Sep 25, 2026: Sep 2026 → Oct 2026, on Nov 4, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Sep 1, 2026
First posted
Sep 4, 2026
StartActual
Oct 8, 2026was Sep 2026
Primary completionEst.
Jul 31, 2027
CompletionEst.
Jul 31, 2027
Last update
Nov 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 4, 2026
Sites
Fu Jen Catholic University Hospital, Fu Jen Catholic University is now Recruiting
Nov 4, 2026
Start date
Sep 1, 2026→Oct 8, 2026 (actual)
Nov 4, 2026
Show all 1 update
  1. Nov 4, 2026
    Not yet recruiting→Recruiting
    Fu Jen Catholic University Hospital, Fu Jen Catholic University is now Recruiting
    Start date Sep 1, 2026→Oct 8, 2026 (now actual)

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07805486
Lead sponsor
Fu Jen Catholic University
Responsible party
Ke-Yun, Chao (Assistant Professor, Fu Jen Catholic University) — Principal investigator
First posted
Sep 4, 2026
Start date
Oct 8, 2026
Primary completion
Jul 31, 2027 (estimated)
Completion
Jul 31, 2027 (estimated)
Last update
Nov 4, 2026

Study contacts

Ke-Yun Chao, PhD
Contact
C00152@mail.fjuh.fju.edu.tw
+886-905-301-879
Ke-Yun Chao, PhD
principal investigator · Fu Jen Catholic University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion